Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Quercetin on the Oxidative Stress and Inflammatory Markers in COPD Phase II

NCT06003270 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT06003270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06003270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Quercetin on the Oxidative Stress and Inflammatory Markers in COPD Phase II
Lead sponsor
Temple University
Phase
Phase 2
Overall status
Unknown status
Start date
November 1, 2023
Completion date
July 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis with airway obstruction, chronic obstructive pulmonary disease, emphysema